GIAMPIETRO, Letizia
 Distribuzione geografica
Continente #
NA - Nord America 5.519
EU - Europa 3.750
AS - Asia 3.634
SA - Sud America 349
AF - Africa 64
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.322
Nazione #
US - Stati Uniti d'America 5.356
SG - Singapore 1.380
CN - Cina 997
IT - Italia 883
IE - Irlanda 461
TR - Turchia 449
UA - Ucraina 416
SE - Svezia 395
RU - Federazione Russa 328
GB - Regno Unito 318
VN - Vietnam 312
BR - Brasile 287
FR - Francia 284
IN - India 254
DE - Germania 219
PL - Polonia 129
FI - Finlandia 118
CA - Canada 111
HK - Hong Kong 50
ES - Italia 42
JP - Giappone 34
BD - Bangladesh 31
MX - Messico 31
AT - Austria 30
ZA - Sudafrica 24
BE - Belgio 23
CZ - Repubblica Ceca 23
LT - Lituania 22
NL - Olanda 20
PK - Pakistan 20
AR - Argentina 16
KR - Corea 15
IQ - Iraq 14
VE - Venezuela 13
CL - Cile 10
ID - Indonesia 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
CO - Colombia 8
DZ - Algeria 8
MA - Marocco 8
GR - Grecia 7
PH - Filippine 7
PT - Portogallo 7
EC - Ecuador 6
IL - Israele 6
KE - Kenya 6
TW - Taiwan 6
CH - Svizzera 5
EG - Egitto 5
ET - Etiopia 5
HR - Croazia 5
AU - Australia 4
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
MY - Malesia 4
PE - Perù 4
AL - Albania 3
BG - Bulgaria 3
CR - Costa Rica 3
HN - Honduras 3
NP - Nepal 3
TT - Trinidad e Tobago 3
YE - Yemen 3
AZ - Azerbaigian 2
EE - Estonia 2
LB - Libano 2
PA - Panama 2
PY - Paraguay 2
SN - Senegal 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EU - Europa 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
MM - Myanmar 1
MT - Malta 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
Totale 13.319
Città #
Singapore 1.049
San Jose 599
Chandler 591
Jacksonville 500
Dublin 455
Ashburn 448
Izmir 286
Beijing 246
Dearborn 243
Chieti 230
Dallas 227
Southend 196
Princeton 187
Nanjing 146
Los Angeles 128
The Dalles 123
Ann Arbor 121
Santa Clara 117
Ho Chi Minh City 109
Cambridge 103
Wilmington 93
Kraków 92
Council Bluffs 82
New York 77
Hanoi 67
Nanchang 67
Altamura 57
Tongling 56
Buffalo 48
Boardman 44
Hong Kong 44
Houston 40
Moscow 40
São Paulo 40
Munich 37
Hebei 35
Warsaw 34
Orem 33
Pescara 32
Teramo 32
Woodbridge 32
Tianjin 31
Toronto 31
Jiaxing 30
Kocaeli 30
Kunming 30
Denver 28
Hefei 28
Helsinki 28
Atlanta 27
Bosa 27
Redondo Beach 27
Tokyo 27
Brooklyn 26
Shenyang 26
Jinan 25
Changsha 24
Ottawa 24
Washington 24
Brussels 23
Montreal 23
Vienna 22
Chennai 21
Milan 21
Brno 20
London 20
Bologna 19
Poplar 19
Rome 19
Da Nang 18
Stockholm 18
Johannesburg 17
Haiphong 15
Hangzhou 15
Norwalk 15
Turku 15
Chicago 14
Frankfurt am Main 14
Ningbo 14
Mumbai 13
Augusta 12
Seattle 12
Amsterdam 11
Mexico City 11
Redwood City 11
San Francisco 11
Seoul 11
Ankara 10
Dong Ket 10
Nuremberg 10
Orange 10
Phoenix 9
San Mateo 9
San Vito Chietino 9
Auburn Hills 8
Boston 8
Como 8
Guangzhou 8
New Delhi 8
Rio de Janeiro 8
Totale 8.248
Nome #
Anticancer Activity of Stilbene-Based Derivatives 193
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 192
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 189
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 188
Synthesis of fibrates analogues and pharmacological evaluation as PPARa agonists 182
Amidine N-sostituite come potenziali inibitori delle Ossido Nitrico Sintasi 178
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 178
Progettazione e sintesi di ossazolidinoni a potenziale attività antibatterica 177
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 172
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 171
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 167
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 167
Asymmetric synthesis of (S)-ibuprofen by esterification with amides of (S)-lactic acid as chiral auxiliaries: experimental and theoretical results 165
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 164
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 163
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 161
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 160
Synthesis of benzothiazolyl-thioalkanoic acids and pharmacological evaluation on PPARa 159
Determinazione della configurazione assoluta di acidi carbossilici a-sostituiti di interesse farmaceutico attraverso spettroscopia NMR 159
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 159
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 157
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 157
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 157
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 157
Anti-Inflammatory, Antioxidant, and WAT/BAT-Conversion Stimulation Induced by Novel PPAR Ligands: Results from Ex Vivo and In Vitro Studies 156
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 156
Blocking the Peroxisome Proliferator-Activated Receptor (PPAR): An Overview 156
Development of a Rapid Mass Spectrometric Determination of AMP and Cyclic AMP for PDE3 Activity Study: Application and Computational Analysis for Evaluating the Effect of a Novel 2-oxo-1,2-dihydropyridine-3-carbonitrile Derivative as PDE-3 Inhibitor 153
Sintesi ed attività antibatterica di 3-cinnamoil e 3-piridinilossazolidin -2-oni 151
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 150
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 150
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 148
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 146
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 146
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 145
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 144
Synthesis and antiplatelet activity of thioaryloxyacids analogues of clofibric acid 143
Synthesis and antiplatelet activity of clofibric acid analogues 141
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 141
Synthesis, biological evaluation and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase 139
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 139
N-acylsulfonamides: synthetic routes and biological potential in medicinal chemistry 139
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 137
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 136
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 134
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 134
Sintesi di analoghi chirali del gemfibrozil 2,5,disostituiti a potenziale attività antiaggregante piastrinica 133
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 133
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 131
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 130
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 129
Dynamic kinetic resolution of α-bromoesters containing lactamides as chiral auxiliaries 128
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 128
null 128
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 128
Structural development studies of PPARs ligands based on tyrosine scaffold 127
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 125
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 125
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 124
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 123
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 123
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 121
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 120
Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine on cellular line H2C9 119
Effect of milrinone analogues on intracellular calcium increase on single living H9C2 cells 119
Development of Fibrates as Important Scaffolds in Medicinal Chemistry 119
PPARα as Potential Therapeutic Target for Neurodegenerative Diseases 117
PPAR-γ agonist GL516 reduces oxidative stress and apoptosis occurrence in a rat astrocyte cell line 117
Synthesis and cytotoxicity evaluation of novel amide and sulfonimide PPARa antagonists 117
Synthesis, biological evaluation and molecular modelling of new PPARa agonists 116
Synthetic strategies for lysine-proline chimeras: an overview 115
Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors 112
Design, synthesis and biological evaluation of aromatase inhibitors based on sulfonates and sulfonamides of resveratrol 112
Sintesi di derivati eterociclici dell’acido clofibrico a potenziale attività antiaggregante piastrinica 111
Effect of milrinone analogues on intracellular calcium increase in single living H9C2 cardiac cells 111
Novel Phenyldiazenyl Fibrate Analogues as PPAR Agonists: Design, Synthesis and Pharmacological Evaluation 110
Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors 110
Identification of new anti-Candida compounds by ligand-based pharmacophore virtual screening 110
Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines 110
Synthesis and Biological Evaluation of Halogenated E-Stilbenols as Promising Antiaging Agents 109
In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on c2c12 and mcf7 cells 109
Capillary electrophoretic enantioseparation of gemfibrozil analogues by use of TM-b-cyclodextrin as chiral selector 108
Synthesis and pharmacological evaluation of gemfibrozil chiral analogues as cardiovascular agents 108
Azobenzene as Multi-Targeted Scaffold in Medicinal Chemistry 107
Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies 105
Methods to Evaluate the Activity of Nitric Oxide Synthase 105
Reversed-phase high-performance liquid chromatography method with fluorescence detection to screen nitric oxide synthases inhibitors. 103
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors 103
Fibrate-Based Analogues as PPARs Agonists: Synthesis and Structure–Activity Relationships 102
PPAR Ligands Containing Stilbene Scaffold 102
QSAR, QSPR and QSRR in terms of 3-D-MoRSE descriptors for in silico screening of clofibric acid analogues 101
A novel life for antitumor combretastatins: Recent developments of hybrids, prodrugs, combination therapies, and antibody-drug conjugates 98
Screening of NOS activity and selectivity of newly synthesized acetamidines using RP-HPLC 98
Stilbene derivatives as new perspective in antifungal medicinal chemistry 98
In vitro evaluation of a new selective iNOS inhibitor on normal rat astrocytes and C6 rat glioma cells 96
Synthetic Approach to Phenylalanine-Proline, and Tyrosine-Proline Hybrid Amino Acids 94
N-Acylsulfonylamides as a new class of PPARa antagonists 91
Sintesi, relazioni struttura-attività e docking di nuovi inibitori delle Ossido Nitrico Sintasi 90
Geometric Isomerism of an Acetamidino Derivative Determined by NMR Investigations 88
Different binding and recognition modes of GL479, a dual agonist of Peroxisome Proliferator-Activated Receptor α/γ 86
Totale 13.338
Categoria #
all - tutte 51.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.202


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202150 0 0 0 0 0 0 0 0 0 0 0 50
2021/2022610 13 9 20 94 52 17 21 42 92 21 75 154
2022/20231.670 124 233 120 167 155 321 79 132 217 20 54 48
2023/2024771 61 32 58 21 49 231 193 10 7 27 6 76
2024/20251.894 72 341 338 46 38 94 73 97 174 99 256 266
2025/20264.288 338 154 394 574 517 263 783 271 424 346 178 46
Totale 13.883